Company recalls anticoagulant
SCA Pharmaceuticals has recalled 10 lots of compounded heparin sodium, an anticoagulant packaged in 500 mL or 1000 mL intravenous bags, the Food and Drug Administration announced yesterday. The bags contain the undeclared benzyl alcohol, a preservative that can cause serious adverse reactions in premature and low birth weight infants.
Related News Articles
Blog
I have the distinct privilege of serving as chair of the American Hospital Association’s Foster G. McGaw Prize Committee, which awards a prize each year to one…
Headline
Doug Brown, partner with Manatt Health and current chair of the AHA’s Foster G. McGaw Prize Committee, discusses how hospitals are tackling food insecurity,…
Headline
Obesity rates for U.S. children and teenagers have reached record highs, while rates for adults had a slight decline, according to reports by the Centers for…
Headline
An American Heart Association study published Feb. 25 found that 6 in 10 U.S. women are projected to develop a form of cardiovascular disease by 2050. The…
Blog
Digital tools are improving access to behavioral health care at a time when demand is increasing. Individuals can use digital access points to better…
Headline
A new AHA blog shares examples of hospitals and health systems working together with Area Agencies on Aging to address the social needs of older adults and…